1-20 of 60
Ulrich Keller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Parallel Sequencing of Transposons and Transcriptomes in Single Cells for Genome-Wide Cancer Gene Discovery

Maximilian Holz, Bertram Klinger, Felix Stuckenbrok, Stefanos A. Bamopoulos, Sanket Gosavi, Caroline Bräuning, Janine Altmüller, Roland Rad, Torsten Haferlach, Nils Blüthgen, Ulrich Keller, Thomas Conrad, Francis Baumgartner
Journal: Blood
Blood (2024) 144 (Supplement 1): 1351.
https://doi.org/10.1182/blood-2024-206939
Published: 2024
Journal Articles

Tracing Clonal Hematopoiesis and Tumor-Specific Mutations in Hematopoietic Progenitors of B Cell Non-Hodgkin Lymphoma (NHL) Patients

Laura Wiegand, Patricia Silva, Daniel Noerenberg, Friederike Christen, Marlon Tilgner, Robert Altwasser, Klara Kopp, Benjamin N. Locher, Pelle F. Löwe, Catarina M. Stein, Vanessa Storzer, Franziska Briest, Jana Ihlow, Anna Dolnik, Naveed Ishaque, Ulrich Keller, Livius Penter, Lars Bullinger, Raphael Hablesreiter, Frederik Damm
Journal: Blood
Blood (2024) 144 (Supplement 1): 44.
https://doi.org/10.1182/blood-2024-199510
Published: 2024
Journal Articles

Data-Informed, Refined Immunophenotypic Classification of Adult T-Lineage Acute Lymphoblastic Leukemia

Stefan Habringer, Iva Todorova, Frederik Herzberg, Daniel Steiert, Arik Horne, Thomas Burmeister, Simon Haas, Ulrich Keller, Monika Brüggemann, Michaela Kotrova, Claudia D Baldus, Nicola Goekbuget, Martin Neumann, Stefan Schwartz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1460.
https://doi.org/10.1182/blood-2024-202301
Published: 2024
Journal Articles

Outcomes of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Multicenter Real-World Analysis

Philipp Berning, David Baden, Philipp Faustmann, Snjezana Janjetovic, Hanna Katharina Zieger, Jan Christian Schroeder, Giuliano Filippini Velazquez, Anna Ossami Saidy, Hristo Boyadzhiev, Tim Sauer, Jan-Henrik Mikesch, Niklas Gebauer, Susanne Ghandili, Paul J. Bröckelmann, Friederike Hildebrand, Veit L. Buecklein, Rebecca Wurm-Kuczera, Ulrich Keller, Georg Lenz, Thomas Pabst, Thomas Melchardt, Claudia Lengerke, Maher Hanoun, Evgenii Shumilov, Ulrike Bacher
Journal: Blood
Blood (2024) 144 (Supplement 1): 3818.
https://doi.org/10.1182/blood-2024-211227
Published: 2024
Journal Articles

Exploiting TCF3-Driven Oncogenic Circuits in Burkitt Lymphoma

Jens Löber, Nazli Serin, Salaheddine Ali, Petra Vockova, Marek Werth, Julia Richter, Marieluise Kirchner, Shashwat Sahay, Hanibal Bohnenberger, Kristyna Kupcova, Rebecca Wurm-Kuczera, Claudia Chapuy, Kirsty Wienand, Kamil Bojarczuk, Viviane Grewe, Jenniffer Günther, Naveed Ishaque, Philipp Ströbel, Philipp Mertins, Ondrej Havranek, Wolfram Klapper, Ulrich Keller, Tomas Etrych, Pavel Klener, Björn Chapuy
Journal: Blood
Blood (2024) 144 (Supplement 1): 230.
https://doi.org/10.1182/blood-2024-209616
Published: 2024
Journal Articles

Real-World Evidence of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, Lenalidomide with or without Polatuzumab (VIPOR(P)) for Relapsed/Refractory Large B-Cell Lymphoma

Rebecca Wurm-Kuczera, Khouloud Kouidri, Meng Wang, Salahedine Ali, Shashwat Sahay, David Winkler, Ann-Kristin Leskien, Samixa Pudasaini, Joseph Kauer, Isabelle Krämer, Marcel Teichert, Niklas Gebauer, Ulf Schnetzke, Thomas Weber, Lukas Peter Frenzel, Anna-Carina Hund, Evgenii Shumilov, Mirjeta Berisha, Jakob Daniel Rudzki, Christian W. Scholz, Dimitrios Mougiakakos, Georg Lenz, Gerald Wulf, Martin Schmidt-Hieber, Bastian von Tresckow, Peter Dreger, Martin Dreyling, Oliver Weigert, Naveed Ishaque, Ulrich Keller, Christiane Pott, Thomas Oellerich, Björn Chapuy
Journal: Blood
Blood (2024) 144 (Supplement 1): 6494.
https://doi.org/10.1182/blood-2024-200002
Published: 2024
Journal Articles

Targeted Treatment Additions Ibrutinib + Bortezomib + R-CHOP for Higher-Risk DLBCL: Efficacy, Feasibility and Molecular Signatures for Future Treatment Decisions

Sophy Denker, Aitomi Bittner, Julia Kase, Mareike Frick, Jörg Hoffmann, Corinna Trenker, Ulrich Keller, Christian Bogner, Andreas Hüttmann, Jan Dürig, Martin Janz, Stephan Mathas, Reinhard Marks, Ulrike Krohn, Il-Kang Na, Paulina Richter-Pechanska, Animesh Bhattacharya, Bernhard Gebauer, Lynn Savic, Norbert Hübner, Altuna Akalin, Roland Eils, Lars Bullinger, Clemens Schmitt
Journal: Blood
Blood (2024) 144 (Supplement 1): 6188.
https://doi.org/10.1182/blood-2024-207123
Published: 2024
Journal Articles

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022

Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, Edward Ayoub, Marietta Truger, Manja Meggendorfer, Miriam Lenk, Gregor Hoermann, Stephan Hutter, Heiko Müller, Wencke Walter, Martha-Lena Müller, Niroshan Nadarajah, Piers Blombery, Ulrich Keller, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach
Journal: Blood
Blood (2024) 143 (12): 1139–1156.
https://doi.org/10.1182/blood.2023021199
Published: 2024
Includes: Supplemental data
Journal Articles

Feasibility and Safety of the First-in-Human Chemotherapy-Light Combination of Rituximab, Polatuzumab Vedotin and Glofitamab in Previously Untreated Aggressive B-Cell Lymphoma Patients Above 60 Years of Age Ineligible for a Fully Dosed R-CHOP - R-Pola-Glo/Ikf-t062, a Study of the Austrian Group for Medical Tumor Therapy (AGMT-NHL-16) and the German Lymphoma Alliance (GLA2022-10)

Thomas Melchardt, Rebecca I Wurm-Kuczera, Bettina Altmann, Petra Pichler, Manuel Orlinger, Michael Panny, Luisa Wohn, Andreas Rosenwald, Dirk Hellwig, Sascha Dietrich, Bertram Glass, Georg Lenz, Ulrich Keller, Marita Ziepert, Richard Greil, Bjoern Chapuy
Journal: Blood
Blood (2023) 142 (Supplement 1): 1734.
https://doi.org/10.1182/blood-2023-188854
Published: 2023
Journal Articles

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Gerald Illerhaus, Andrés J.M. Ferreri, Mascha Binder, Peter Borchmann, Justin Hasenkamp, Stephan Stilgenbauer, Alexander Roeth, Thomas Weber, Gerlinde Egerer, Thomas Ernst, Bernd Hertenstein, Georg Lenz, Guido Kobbe, Uta Brunnberg, Christian Schmidt, Michael Kneba, Martin Dreyling, Robert Möhle, Jens Panse, Thomas Heinicke, Sebastian Schroll, Thomas S. Larsen, Hans Salwender, Ralph Naumann, Georg Hess, Lorenz Thurner, Tobias Pukrop, Ulrich Keller, Anne Kirsti Blystadt, Frank P. Kroschinsky, Francesca Re, Elisa Pulczynski, Lorella Orsucci, Lisa Pospiech, Martina Deckert, Maurilio Ponzoni, Julia Wendler, Elke Valk, Teresa Calimeri, Benjamin Kasenda, Martin Trepel, Heidi Fricker, Philipp von Gottberg, Elvira Burger, Gabriele Ihorst, Olga Grishina, Claudia Hader, Emanuele Zucca, Jürgen Finke, Elisabeth Schorb
Journal: Blood
Blood (2022) 140 (Supplement 2): LBA-3.
https://doi.org/10.1182/blood-2022-171733
Published: 2022
Journal Articles

Collections of Autologous Lymphocytes for Treatment with Chimeric Antigen Receptor (CAR) T-Lymphocytes - No Association of Clonal Hematopoiesis (CH) with Manufacturing Success

Simon M. Krauss, Konstantin Weibl, Enrica Bach, Mandy Brückner, Anne Weigert, Theresa Tumewu, Florian Ramdohr, Elena Ruschpler, Gunhild Vogtmann, Sandra Hoffmann, Olaf Penack, Martin Janz, Raymund Buhmann, Reinhard Henschler, Lars Bullinger, Ulrich Keller, Sebastian Schwind, Maximilian Merz, Madlen Jentzsch, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Klaus H. Metzeler, Vladan Vucinic
Journal: Blood
Blood (2022) 140 (Supplement 1): 7560–7562.
https://doi.org/10.1182/blood-2022-163360
Published: 2022
Journal Articles

Therapy-Related AML: Clinical/Biological Features and Long-Term Outcome in a Cohort of 1133 Adult AML Patients

Sophia Gross, Jana Ihlow, Leonie Busack, Kacper Adamiak, Jens F. Schrezenmeier, Julia Jesse, Michaela Schwarz, Anne Floercken, Kathrin Rieger, Jan Krönke, Philipp le Coutre, Vivien Boldt, Ann-Christin von Bruenneck, David Horst, Thomas Burmeister, Igor Wolfgang Blau, Ulrich Keller, Lars Bullinger, Joerg Westermann
Journal: Blood
Blood (2022) 140 (Supplement 1): 1291–1292.
https://doi.org/10.1182/blood-2022-164798
Published: 2022
Journal Articles

Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) - Real-World Data from Two German Academic Centers

Laura K. Schmalbrock, Krischan Braitsch, Paul Jung, Irmgard Bumeder, Philipp Kiewe, Jörg Westermann, Lars Bullinger, Ulrich Keller, Florian Bassermann, Jan Krönke, Kathrin Rieger, Katharina S. Goetze
Journal: Blood
Blood (2021) 138 (Supplement 1): 1257.
https://doi.org/10.1182/blood-2021-150943
Published: 2021
Journal Articles

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Clinical Trials & Observations
Norbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, Marita Ziepert, Mathieu Leclerc, Guillaume Cartron, Arnaud Jaccard, Peter Reimer, Eva Wagner, Martin Wilhelm, Laurence Sanhes, Thierry Lamy, Laurence de Leval, Andreas Rosenwald, Muriel Roussel, Frank Kroschinsky, Walter Lindemann, Peter Dreger, Andreas Viardot, Noël Milpied, Christian Gisselbrecht, Gerald Wulf, Emmanuel Gyan, Philippe Gaulard, Jacques Olivier Bay, Bertram Glass, Viola Poeschel, Gandhi Damaj, David Sibon, Alain Delmer, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Bernd Metzner, Ulrich Keller, Friederike Braulke, Birte Friedrichs, Maike Nickelsen, Bettina Altmann, Olivier Tournilhac
Journal: Blood
Blood (2021) 137 (19): 2646–2656.
https://doi.org/10.1182/blood.2020008825
Published: 2021
Includes: Supplemental data
Journal Articles

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

Sarah Reinke, Paul J. Bröckelmann, Ingram Iaccarino, Maria Garcia-Marquez, Sven Borchmann, Franziska Jochims, Michaela Kotrova, Karol Pal, Monika Brüggemann, Elena Hartmann, Stephanie Sasse, Carsten Kobe, Stephan Mathas, Martin Soekler, Ulrich Keller, Matthias Bormann, Andreas Zimmermann, Julia Richter, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Hans Schlößer, Michael von Bergwelt-Baildon, Andreas Rosenwald, Andreas Engert, Wolfram Klapper
Journal: Blood
Blood (2020) 136 (25): 2851–2863.
https://doi.org/10.1182/blood.2020008553
Published: 2020
Includes: Supplemental data
Journal Articles

Fast-Track Schedule for Vitamin D3 Substitution in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Jonas Matthias Jabs, Viola Poeschel, MD, Martin Sökler, MD, Kerstin Habersang, MD, Rolf Mahlberg, MD, Ulrich Keller, Professor Dr, Heinz-Gert Hoeffkes, Professor Dr, Andreas Rank, PD Dr, Andreas Viardot, Professor Dr, Andreas Neubauer, Professor Dr, Marita Ziepert, PhD, Bettina Altmann, PhD, Stephan Stilgenbauer, MD, Michael Pfreundschuh, Professor Dr, Gerhard Held, Professor Dr, Joerg Thomas Bittenbring, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-134944
Published: 2020
Journal Articles

MyD88 L265P Mutation-Specific TCR Gene Therapy for Treatment of B-Cell Lymphoma and Leukemia

Özcan Çinar, BSc,MSc, Peter Michael Kloetzel, Caroline Anna Peuker, Ulrich Keller, Antonio Pezzutto, Antonia Busse
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-142880
Published: 2020
Journal Articles

Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial

Paul J Bröckelmann, MD, Helen Goergen, Dipl.-Math., Ulrich Keller, Julia Meissner, MD, Karolin Trautmann, MD, Teresa V Halbsguth, MD, Stephanie Sasse, MD, Martin Sökler, MD, Andrea Kerkhoff, MD, Stephan Mathas, MD, Andreas Hüttmann, MD, Matthias Bormann, MD, Andreas Zimmermann, MD, Michael Fuchs, Bastian von Tresckow, MD, Christian Baues, MD, Andreas Rosenwald, MD, Wolfram Klapper, MD, Carsten Kobe, MD, Peter Borchmann, MD, Andreas Engert, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-138413
Published: 2020
Journal Articles

Polatuzumab Vedotin in Relapsed and Refractory (r/r) Large B-Cell Lymphoma (LBCL): Real-World Data of the German National Compassionate Use Program (CUP)

Nora Liebers, MD, Johannes Duell, MD, Daniel Nörenberg, MD, Eva Kaebisch, MD, Andrea Kerkhoff, MD, Fabian Acker, MD, Stephan Fuhrmann, MD, Corinna Leng, MD PhD, Manfred Welslau, MD, Jens Chemnitz, MD, Jan Moritz Middeke, MD, Thomas Weber, MD, Ralf Ulrich Trappe, MD, Roald Pfannes, MD, Ruediger Liersch, MD, Christian Spoer, MD, Niklas Gebauer, MD, Stefan Fuxius, MD, Léandra Caillé, Christiane Pott, MD PhD, Christian Koenecke, MD, Udo Holtick, Thomas Geer, MD, Ulrich Keller, MD, Rainer Claus, MD, Dimitrios Mougiakakos, MD, Stephanie Mayer, MD, Andreas Hüttmann, MD, Arne Trummer, MD, Gerald Wulf, MD, Uta Brunnberg, MD, Lars Bullinger, MD, Georg Hess, MD, Carsten Mueller-Tidow, MD, Bertram Glass, MD, Georg Lenz, Peter Dreger, MD, Sascha Dietrich, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-136539
Published: 2020
Journal Articles

CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

Peter Herhaus, MD, Jana Lipkova, Felicitas Lammer, MD, Julia Slotta-Huspenina, MD, Benedikt Wiestler, MD, Tibor Vag, MD, Stefan Habringer, MD, Igor Yakushev, MD, Constantin Lapa, MD, Tobias Pukrop, MD, Dirk Hellwig, MD, Andreas Buck, MD, Martina Deckert, MD, Hans-Jürgen Wester, PhD, Florian Bassermann, MD PhD, Wolfgang Weber, MD, Markus Schwaiger, MD, Björn Menze, PhD, Ulrich Keller, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2900.
https://doi.org/10.1182/blood-2019-126024
Published: 2019